159 related articles for article (PubMed ID: 6215008)
1. Piperacillin v Carbenicillin in the therapy for serious infections.
Marier RL; Sanders CV; Faro S; Janney A; Williams WW; Derks F; Aldridge KE
Arch Intern Med; 1982 Oct; 142(11):2000-5. PubMed ID: 6215008
[TBL] [Abstract][Full Text] [Related]
2. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of piperacillin therapy for infection.
Pancoast S; Prince AS; Francke EL; Neu HC
Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
Sharifi R; Lee M; Ojeda L
Urol Int; 1984; 39(6):345-51. PubMed ID: 6395464
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
Swarifi R; Lee M; Ojeda L; Tabib M
J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
11. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
Russo J; Russo ME
Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
13. [Carbenicillin in resuscitation. Indications and results apropos of 30 cases of severe infections].
Wattel F; Martin G; Scherpereel P; Wattel-Warembourg N; Fruchart A; Asseman P
Lille Med; 1974 Oct; 19(8 Suppl 3):678-83. PubMed ID: 4618591
[No Abstract] [Full Text] [Related]
14. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin.
Lutz B; Mogabgab W; Holmes B; Pollock B; Beville R
Antimicrob Agents Chemother; 1982 Jul; 22(1):10-4. PubMed ID: 6214992
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Vestweber KH; Grundel E
Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
[TBL] [Abstract][Full Text] [Related]
18. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Graham DR; Lucasti C; Malafaia O; Nichols RL; Holtom P; Perez NQ; McAdams A; Woods GL; Ceesay TP; Gesser R
Clin Infect Dis; 2002 Jun; 34(11):1460-8. PubMed ID: 12015692
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cefamandole and carbenicillin in preventing sepsis following penetrating abdominal trauma.
Lou MA; Thadepalli H; Sims EH; Mandal AK
Am Surg; 1985 Oct; 51(10):580-6. PubMed ID: 4051334
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
